RxDoctor Payments Data

Jessica Kline, DO

Clinical Cardiac Electrophysiology · Kansas City, MONPI 1679993760

Payments from drug & device makers

What this record shows

This record is dominated by grants: $52,010 of the $74,672 with a category attached, or 69.7%. Medtronic accounts for 65.3% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $37,983 and has fallen 99.5% since, to $206 in 2025. Among clinical cardiac electrophysiology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$74,672in general payments, 2019–2025

Across 186 payments — averaging $401.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$49K
  • Boston Scientific$20K
  • Abbott$4K
  • Biosense Webster, Inc.$646
  • Medical Device Business Services, Inc.$620
  • Siemens Medical Solutions USA, Inc.$144
  • plus $222 from 4 others

What the payments were for

  • Speaking & faculty fees$10,37514%
  • Grants$52,01070%
  • Travel & lodging$5,7748%
  • Food & beverage$6,1248%
  • Education$3891%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$74,672 in reported general payments places this provider in the 95th percentile of 74 clinical cardiac electrophysiology providers in Missouri.

See all clinical cardiac electrophysiology providers in Missouri

Medicare billing

Part B allowed, 2024
$231,066
Medicare patients
1,546
Services billed
3,675

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban281$290,529
XareltoRivaroxaban38$38,366
EntrestoSacubitril/Valsartan18$26,352
JardianceEmpagliflozin14$8,193
Dofetilide39$7,121
Flecainide Acetate62$2,886
Metoprolol Succinate164$1,703
Diltiazem 24hr Er (Cd)Diltiazem Hcl64$1,648
Amiodarone Hcl70$895
SotalolSotalol Hcl22$657
Carvedilol57$427
Atorvastatin Calcium57$394
Amlodipine Besylate31$327
Torsemide13$299
Losartan Potassium44$284

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$18$8,19314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 74 clinical cardiac electrophysiology providers in Missouri.

Other clinical cardiac electrophysiology in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →